chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Case number PHHY2011US32369 is an initial report from a non-health care professional received on 06 Apr 2011: This patient received seasonal influenza virus vaccine (manufacturer and batch number unknown) on an unspecified date. She presented with spinal cord problems after getting the flu shot. No further information was available at the time of this report.
3/27/2021 vaccination Couple hours later, I got home. I got up to go down the stairs, my leg felt weak and I fell to the ground. I tried to get up but couldn't get up. My husband tried to get me up but couldn't. I crawled to the couch. My son came lifted me up, gave me a walker and I walked to my bed. I laid down and was there for quite a while, few days with loss of energy. I had a HA during these days. Called my Doctor the next day and said I could not take Tylenol, to just rest. No temp. Couple days later, HA still there but I could function. The HA lasted for about a week.  *still experiencing the fatigue, weakness  *virtual telehealth appt upcoming
Increase in blood pressure/preeclampsia; This is a spontaneous report from a contactable other healthcare professional (patient). This other healthcare professional reported information for both mother and fetus/baby. This is a maternal report. A 39-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in left arm on 02Apr2021 11:00 (Batch/Lot Number: Ep7833) as 1ST DOSE, SINGLE for COVID-19 immunisation. Medical history included allergy to penicillin. Date of LMP was 15Aug2020. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. Concomitant medications were not reported. The patient previously took TDAP on 03Mar2021 for immunization. The mother reported she became pregnant while taking bnt162b2. On 05Apr2021 12:00, the patient experienced increase in blood pressure. She developed preeclampsia after first injection. The event caused hospitalization. The mother was 33 weeks pregnant at the onset of the event. The mother was due to deliver on 22May2021. The mother delivered the pregnancy. The baby was delivered premature. The patient delivered the baby at 33 weeks 5 days. Therapeutic measures were taken as a result of increase in blood pressure/preeclampsia and included treatment with blood pressure (BP) medication. Blood pressure returned to normal levels 3 weeks post-partum. Outcome of the event was recovering.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the event, Preeclampsia cannot be completely ruled out. The impact of this report on benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethic committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021516156 fetus case
mom states that pt had vax 24JUN97 115PM;pt given APAP on evening of vax;little fussy;refused to eat approx 11AM on 25JUN97 pt awoke screaming until 730AM when finally fell asleep;t102;RT was red, swollen, hot to touch;
22JUL92 exp a "spell" (sz) characterized by unresponsiveness & eyes rolling-lasting 1 min, followed by sleep for 4 hrs; occurred again in hosp on 22JUL;
Starting 12/25/2021, I had a constantly runny nose and shortness of breath. I thought it was related to the incense being burned in the house. The next day, I still had a runny nose and was coughing. I felt like I was getting a little bit of a fever and was feeling achy. So I decided to get tested for COVID-19. On 12/27/2021, I went to get tested for COVID-19 (both rapid and PCR) and both came back negative. By then, I had fever, chills, cough, achiness, slight shortness of breath. By 12/28/2021, the shortness of breath was getting worse and I noticed my pulse oximeter alarm was going off due to my lower than normal oxygen levels. Also, the cough was so severe I couldn't catch my breath. So, I started using my inhaler and then I started to do breathing treatments on my own. I wasn't able to take off/rest which was exacerbating my symptoms. A week later I sought treatment due to my  symptoms not getting better. I was prescribed large doses of steroids (both inhaled and oral) and they gave me benzoate capsules to help with the cough. I still had a cough for 3-4 weeks after. The next month, the cough was getting better and the symptoms were less severe and more intermittent. However, it would not be until a month later that the cough would resolve. When the cough finally resolved, I developed long COVID-19 symptoms. I never tested positive for COVID-19. I am still experiencing long COVID-19 symptoms to this day but they are not as bad as before. I had extreme lethargy and tachycardia. My hair started falling out and I would have random joint pains and deep muscle pains in my calf. The extreme tiredness has resolved. However, if I exert myself at all, I get short of breath and now need my rescue inhaler daily. I used to be a fast walker and now I need people to slow down to walk with me. My hair is still coming out and I am still having random nerve pains in my calf but not as bad as before. Hopefully, I'm turning the corner with the long COVID-19.
Red knot on right leg at site of vaccines- advised office on 9/29/2016.
Bad headache, muscle pain over entire body, chills ,then hot, 101.7 fever. I just slept a lot ,drank lots of water, everything but the muscle ache is gone
itching inc chest, swollen face, pimple on chest, flushing over body;
Drug allergy; This spontaneous case was received on 26-Apr-2021 from other non-health professional (reference number: NUS2021US024669/NC_PK) and concerned a 66-year-old, female patient.  The patient's medical history and concomitant medications were not reported.    On an unknown date, the patient was vaccinated with influenza virus vaccine polyvalent (brand not specified; route of administration, indication, dose and anatomical location: not reported). The batch number was not reported.   On an unknown date, unknown amount of time after receiving influenza virus vaccine polyvalent, the patient developed drug allergy.  The outcome of event was not reported.   The reporter did not provide causality assessment.  Company comment: A 66-year-old, female patient was vaccinated with influenza virus vaccine polyvalent. On an unknown date, unknown amount of time after receiving influenza virus vaccine polyvalent, the patient developed drug allergy. The patient's medical history was not reported. Causal role of the suspect vaccine is unassessable, due to unclear information regarding temporal relationship and diagnostic findings.; Sender's Comments: A 66-year-old, female patient was vaccinated with influenza virus vaccine polyvalent. On an unknown date, unknown amount of time after receiving influenza virus vaccine polyvalent, the patient developed drug allergy. The patient's medical history was not reported. Causal role of the suspect vaccine is unassessable, due to unclear information regarding temporal relationship and diagnostic findings.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In May 2017, the patient was inoculated with ZOSTAVAX at a community health center as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On an unspecified date, the patient was treated at the same community health center for a blistering vesicular outbreak that was diagnosed as severe herpes zoster. As a direct and proximate result of ZOSTAVAX, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
This spontaneous report was received from a medical assistant, and refers to a currently 21 year old male patient. The patient medical history included chicken pox whose was "never vaccinated". The patient had none concomitant medications, drug reaction or allergies. On 05-SEP-1998, the patient was vaccinated with the first dose of RECOMBIVAX HB (lot number, route of administration and expiration date unknown by reporter), on 29-OCT-1998, the patient received the second dose of RECOMBIVAX HB, lot# 2712B2 (route of administration and expiration date unknown by reporter) and on 15-MAR-1999, the third dose of RECOMBIVAX HB lot# 272612 (route of administration and expiration date unknown by reporter) for prophylaxis. On an unknown date, in January 2019, the patient had a negative Hepatitis B titer (Anti-HBs antibody negative). On 31-JAN-2018, the patient was vaccinate with a pediatric dose of RECOMBIVAX HB (lot number, dose, route of administration and expiration date were not reported). An unspecified treatment for the event was given at the time of this report the patient had not recovered from the events. The patient sought medical attention and no overdose or hospitalization were reported. Lots# 2712B2 and 272612 are invalid for RECOMBIVAX HB.
MODERATE TO SEVERE CHICKEN POX TOTAL OF 100-120 LOW GRADE FEVER LOSS OF APPETITE
Symptoms started 4-6 hours post vaccination. Chills, sinus pressure, headache, fatigue, itching to soles of feet. Symptoms progressed over next several days to include fever 102.3,  sore throat, dry cough, laryngitis. Symptoms still present today, 7 days post vaccination.  No treatment except for supportive measures to include pushing oral hydration, and alternating Tylenol and Advil.
Psoriasis symptoms within a month of second vaccine dose. Developed into sever outbreak of psoriasis resulting in psoriatic arthritis of the right wrist. No history of psoriasis prior to vaccine event. No abnormal life events during the same period.
She received vaccine by the nurse, after a minute or two she was seen talking on her phone, phone slipped from hand and she fell to the floor. The nurse attended to her, I called 911.  The police came and asked her some questions, she responded. Paramedics came and I believe they took her to a hospital
administered PENTACEL without the ACTHIB diluent (with no adverse event); Initial information was received on 23-Nov-2020 regarding an unsolicited valid non-serious case from an other health professional.  This case involves a 5 months old female patient who was administered Pentacel without the Acthib diluent (with no adverse event) (Product administration error), while she received vaccine diphtheria/tetanus/5 hybrid AC pertussis/IPV (MRC5)/HIB(PRP/T) vaccine (Pentacel).  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included pneumococcal vaccine conj 7V (CRM197) (Prevnar) and rotavirus vaccine.  On an unknown date, the patient received a dose of diphtheria/tetanus/5 hybrid AC pertussis/IPV (MRC5)/HIB(PRP/T) vaccine at a dose of 0.5 mL once via unknown route (lot: U6540AA, expiry dates were unknown) for immunization in unknown administration site.  On an unknown date (latency unknown)  after taking the suspect, the patient who was administered Pentacel without the Acthib diluent (with no adverse event) (Product administration error) (intensity: not applicable).  No laboratory test was reported.   Action taken was reported as not applicable. Therapy status was unknown. Corrective treatment was not reported. Outcome was reported as not applicable for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001-83-EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.    No further information was reported.
I got my second covid vaccine on may 15 at 1:00pm and at 7:00pm I started getting painful hives on my legs.
sometimes gets stomach aches; she's not hungry; She's get down;not on a regular schedule and not living her normal life; first night everything was hurting / soreness in the arm from both shots that lasted about a week; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (sometimes gets stomach aches), DECREASED APPETITE (she's not hungry), DEPRESSED MOOD (She's get down;not on a regular schedule and not living her normal life), MYALGIA (first night everything was hurting / soreness in the arm from both shots that lasted about a week) and HEADACHE (Headaches) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (sometimes gets stomach aches), DEPRESSED MOOD (She's get down;not on a regular schedule and not living her normal life), MYALGIA (first night everything was hurting / soreness in the arm from both shots that lasted about a week) and HEADACHE (Headaches). 15-Apr-2021, the patient experienced DECREASED APPETITE (she's not hungry). At the time of the report, ABDOMINAL PAIN UPPER (sometimes gets stomach aches), DECREASED APPETITE (she's not hungry), DEPRESSED MOOD (She's get down;not on a regular schedule and not living her normal life), MYALGIA (first night everything was hurting / soreness in the arm from both shots that lasted about a week) and HEADACHE (Headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Apr-2021, Heart rate: 100 (High) 100.         Relevant concomitant medications were not reported.  Treatment information was not provided.   Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-092344 (Patient Link).
Redness, warmth, and soreness at the injection site has reappeared. Initially soreness / redness lasted for a day or so. Also accompanied by increased fatigue.
Information has been received from a physician concerning a male with positive skin test for egg and soy (physician stated not a clinical allergy to soy) and a history of cleft palate syndrome who on 29-Nov-2006 was vaccinated his first dose of VARIVAX (Oka/Mereck) at the primary health care provider's office. Suspect vaccination administered on that same day included a dose of influenza virus vaccine (unspecified). Post vaccination the patient had an anaphylactic reaction, was treated and monitored and was not hospitalized. Subsequently the patient recovered . On 21-May-2008 at 3 years of age, the patient was vaccinated with his second dose of VARIVAX (Oka/Mereck) at the same primary care provider's office and other vaccines. At 15 minutes post-vaccination, the patient experienced a second occurrence of anaphylactic reaction in the parking lot and was taken back into the doctor's office, treated and taken by ambulance to the hospital. The child was hospitalized for 24 hours and treated with epinephrine, anti-histamines and oral steroids. The child had a follow-up visit with the physician. Subsequently, the patient fully recovered. Follow-up information has been received from a physician concerning an 18 month old male patient who's initial initial episode of anaphylaxis occurred on 29-Nov-2006. During that visit, he had also received PEDIARIX, (Oka/Merck) and influenza vaccine. This was his primary immunization to the VARIVAX (Oka/Merck). He went to develop fitful sneezing, copious rhinorrhea, facial and periorbital edema. He was treated with epinephrine and Benadryl and cleared promptly. He subsequently was skin test positive to egg but had not been skin tested to the individual vaccines. On 21-May-2008 the patient received the second dose of VARIVAX (Oka/Merck). He went on to develop a similar but more severe reaction with copious rhinorrhea, fitful sneezing, generalized urticaria, wheezing and labored breathing. The patient was treated with epinephrine and Benadryl and was transported via 911 to a local emergency room. There he went to develop a late-phase reaction with recurrence of similar symptoms but also had some hypotension with systolic blood dropping into the 50s. The patient received additional emergency care, IV fluids, and recovered with no sequela. Anaphylactic reaction was considered to be immediately life-threatening and another important medical event by the physician. Additional information has been requested.
Approx 3 hours after receiving vaccine, noticed blurry vision and when looking straight on at someone, was unable to see their face. Blinked a few times and tried to refocus, but anything that I looked straight on at was blurry. Progressively worsened and now central vision completely blurred out. Peripheral vision ok, but obvious blind spot when I look straight on at something or someone.
Patient was faint, light headed, throat swelling, had a history of anaphylaxis, gave epinephrine injection in left thigh, called 911 and ems took her to hospital
The product reached room temperature for a cumulative time of 45 minutes. Caller states the excursion was due to a patient refusing the product after it had been prepared, no ae; Initial information received on 11-Nov-2019 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a patient who was supposed to receive vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] lot number not reported.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was potential medication error case due to incorrect product storage. The product reached room temperature for a cumulative time of 45 minutes. Caller states the excursion was due to a patient refusing the product after it had been prepared   No AE had been reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  Information on the batch number was requested.
No energy; no appetite; hot & cold; body aches; Very hoarse; coughing; This is a spontaneous report from a contactable consumer. A 77-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: unknown), via an unspecified route of administration in left arm on 14Jan2021 at 12:45 as single dose for COVID-19 immunization. Medical history was not reported. Patient had no known allergies. Concomitant medications included ezetimibe, tamsulosin, amlodipine, sumatriptan, finasteride and tadalafil. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 16Jan2021 at 01:00 PM, patient experienced no energy, no appetite, hot & cold, body aches. very hoarse, coughing-No fever. On 25Jan2021, the patient was tested negative for COVID-19 via nasal swab. No treatment was received for the adverse events. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
The second Shingles vaccine shot is throwing me for a loop. My left arm, where the shot was given, was out of commission for the rest of the day. It was difficult to have restful sleep last night with a very sore arm. I started having chills but my body's temperature was warm with tense headache and bodily pain in the back of my neck. I took 2 TYLENOL PM last night but they didn't help. I understand that this is to be expected according to the medical literature. I am still going through the adverse reaction but I am hoping that these symptoms will subside after tomorrow.
Patient was fine for several hours and was out shopping.  Developed headache and dizziness.  called wife to pick him up.  by time she got there he had developed vomiting.  was taken to ER and subsequently admitted to hospital  with rotary nystagmus in right eye and slightly less nystagmus in left eye, vertigo, vomiting.
Second dose was given 21 days out since first dose. Patient was informed that is not recommended, but still he wished to receive 2nd dose. No adverse event or allergic reactions.
Very bad fever up and down highest 102. Fever for four days it would go up and down never constant . Very hot legs arms and back.